Advanced search

News (26)

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results GL
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors GL
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors AQ
Absci Corporation Appoints Menelas Pangalos as Class II Director and Member of Compensation Committee of the Board, Effective January 1, 2024 CI
AstraZeneca : asks FDA to authorize COVID antibody treatment AQ
AstraZeneca : Vaccine Trial Data Underscore Safety, Range of Efficacy -- 2nd Update DJ
AstraZeneca : Vaccine Trial Data Underscore Safety, Range of Efficacy -- Update DJ
BioNTech : US signs contract with Pfizer for COVID-19 vaccine doses AQ
AstraZeneca : Coronavirus vaccine developers vow diversity in clinical trials RE
AstraZeneca : Update on Phase III clinical trials of lanabecestat for Alzheimer’s disease PU
Eli Lilly and : Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease PR
Bicycle Therapeutics : Expands Strategic Partnership with AstraZeneca BU
Bicycle Therapeutics : Expands Strategic Partnership with AstraZeneca BU
X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca BU
Moderna Announces New Collaboration with AstraZeneca to Co-Develop and Co-Commercialize Relaxin mRNA Therapeutic for Heart Failure BU
Bicycle Therapeutics : Announces Broad Partnership with AstraZeneca to Develop Bicyclic Peptides (Bicycles™) BU
Bicycle Therapeutics : Announces Broad Partnership with AstraZeneca to Develop Bicyclic Peptides (Bicycles®) BU
Eli Lilly : and Company : and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease PR
Four Prestigious NEDs Join Precision Medicine Catapult Board BU
AstraZeneca : and MRC Laboratory of Molecular Biology to launch joint research fund PU
AstraZeneca : and MRC enter strategic collaboration to create new centre for early drug discovery in Cambridge, UK PU
AstraZeneca plc : AstraZeneca closes in on site for new home in Cambridge RE
AstraZeneca plc : AstraZeneca and Karolinska Institutet to create Integrated Translational Research Centre PU
AstraZeneca plc : AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimer's Disease Research PR
AstraZeneca plc : AstraZeneca Acquires Neuroscience Assets From Link Medicine PR
PFIZER : plans two research chiefs upon Wyeth merger RE

Insiders

Picture Menelas Pangalos
Menelas Pangalos

Menelas N. Pangalos is EVP-Biopharmaceuticals Research & Development at AstraZeneca Plc, Member of Society For Neuroscience and Member of British Pharmacological Society and on the board of 5 other companies. In his past career Dr. Pangalos occupied the position of Chief Scientific Officer & Senior Vice President at Neuroscience Research Australia. He received an undergraduate degree from Imperial College London and a doctorate from the University of London.

Picture Nicolas Pangalos Menelas
Nicolas Pangalos Menelas

No results for this search

  1. Stock Market
  2. Advanced search
  3. Menelas Pangalos
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW